• gmp-verlag.de
  • GMP Compliance Adviser Login
  • Shopping cart
Stay informed!

You’d like to be regularly informed on the latest developments in Good Manufacturing Practices?


Subscribe to our free GMP Newsletter LOGFILE!


GMP Compliance Adviser

GMP in Practice: 24 chapters written by internationally renowned industry experts.


GMP Regulations: 8 chapters with the most important GMP guidelines and regulations.




Award for the
GMP Compliance Adviser

GMP knowledge that convinces.


On 7 June 2016 Maas & Peither GMP Publishing has received a

SIPAward in the category
"Best New Success Story" and was awarded with the 3rd place.

The GMP MANUAL (now: GMP Compliance Adviser) impressed the jury with "Safe Drugs through Better GMP Understanding".

TOP 5 GMP Downloads

1. Questionnaire for preparing GMP-inspections
More than 650 typical questions related to audits and inspections.

2. GMP Fundamentals
A quick and comprehensive overview of the complex world of GMP.

3. GDP Audit Questionnaire
More than 700 questions with reference to regulations.

4. A Pharma Guide to Cleaning Validation
How to meet Agency Expectations and Establish Accepted Limits.

5. Data Integrity in the EU
Requirements for Quality Management Systems.

>>> More Downloads

News about GMP/cGMP


ICH: Final Concept Paper to ICH Q13 „Continuous Manufacturing“

The Management Committee of the ICH has endorsed the final concept paper and business plan on the new quality guideline ICH Q13 on continuous manufacturing for drug substances and drug products. Both documents are published on the ICH website.


The proposed new quality guideline shall

  • harmonise CM-related definitions
  • articulate key scientific approaches for CM, and
  • harmonise regulatory concepts and expectations for CM across the regions.

According to the published business plan, the objectives of ICH Q13 are to

  • capture key technical and regulatory considerations including certain CGMP elements specific to CM
  • allow drug manufacturers to employ flexible approaches to develop, implement, or integrate CM for the manufacture of small molecules and therapeutic proteins for new and existing products, and
  • provide guidance to industry and regulatory agencies regarding regulatory expectations on the development, implementation, and assessment of CM technologies.

An Expert Working Group with 35 experts has set a time frame from November 2018 – November 2021, to reach Step 4 of the ICH process. A step 2b document can be expected in June 2020.


ICH Q 13: Business Plan and Concept Paper


No comment has yet been written about this news.
Literature recommendation
GMP Compliance Adviser
Single User Licence (monthly subscription)